[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100604452":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":10,"centralContacts":10,"locations":10,"responsibleParty":20,"collaborators":10,"id":22,"slug":23,"hasResults":24,"nctId":25,"briefTitle":26,"officialTitle":26,"acronym":10,"eligibilityCriteria":27,"healthyVolunteers":24,"sex":28,"minAge":10,"maxAge":10,"enrollmentInfo":29,"targetDuration":32,"studyType":33,"phases":10,"briefSummary":34,"conditions":35,"keywords":10,"overallStatus":37,"whyStopped":10,"lastUpdateSubmitDate":38,"lastUpdatePostDateStruct":39,"startDateStruct":42,"completionDateStruct":44,"leadSponsor":46,"locationsCount":10},{"fullName":5,"class":6},"Beijing Anzhen Hospital","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Normal treatment",null,"Treatment without intervention of catheter ablation or Implantable cardioverter defibrillator.",[13],"Device: Intervention",[15],{"type":16,"name":17,"description":18,"armGroupLabels":19,"otherNames":10},"DEVICE","Intervention","Treatment with intervention of catheter ablation or Implantable cardioverter defibrillator.",[9],{"type":21,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR","100604452","ventricular-tachycardia-cohort-100604452",false,"NCT07149701","Ventricular Tachycardia Cohort","Inclusion Criteria:\n\n* Sustained ventricular tachycardia (VT), defined as VT lasting ≥30 seconds or requiring intervention due to hemodynamic compromise within 30 seconds; or Clinically significant non-sustained VT (NSVT) where the treating clinician has determined that therapeutic intervention is necessary.\n\nExclusion Criteria:\n\n* Concurrent participation in any interventional clinical trial that, in the judgment of the investigator, could interfere with the data collection or outcome assessment of this observational study.","ALL",{"count":30,"type":31},1500,"ESTIMATED","8 Years","OBSERVATIONAL","The goal of this observational study is to detect the long-term risk of a composite endpoint event in adult patients with ventricular tachycardia (VT) who are managed with catheter ablation or non-ablation management (including modern drug therapy and\u002For ICD therapy).",[36],"Ventricular Tachycardia (VT)","NOT_YET_RECRUITING","2025-08-24",{"date":40,"type":41},"2025-09-02","ACTUAL",{"date":43,"type":31},"2025-09-01",{"date":45,"type":31},"2029-12-01",{"name":5,"class":6}]